Results 141 to 150 of about 15,628 (311)

FAER and Others [PDF]

Anesthesiology, 2011
openaire   +1 more source

Istradefylline Safety Profiles: Examination of Individual Case Safety Reports in the FDA Adverse Event Reporting System (FAERS) Database [PDF]

WU Wen-hua, Haoxin Liang, Zhengrui Chen, Shuzhen Zhu   +3 more
openalex   +1 more source

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases

Frontiers in Pharmacology
Background Gonadotrophin-releasing hormone analogs (GnRHas) play a significant role in addressing gynecological diseases, central precocious puberty, and cancer.
Shupeng Zou, Meng-ling Ouyang, Yazheng Zhao, Qian Cheng, Xu Shi, Minghui Sun   +5 more
semanticscholar   +1 more source

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for bimekizumab

Frontiers in Pharmacology
BackgroundBimekizumab, a humanized monoclonal antibody, exerts its therapeutic effect by inhibiting interleukin-17A/F and is indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients.
Zhuomiao Lin, Xihui Yu, Meiqing Yang, Jialan Xu, Jiahong Zhong   +4 more
doaj   +1 more source

Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database [PDF]

Qingqing Li, Jijun Zhang, Chuanli Yang, Xiushan Dong, Yan Wang   +4 more
openalex   +1 more source

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

Frontiers in Pharmacology
Background Donepezil in combination with memantine is a widely used clinical therapy for moderate to severe dementia. However, real-world population data on the long-term safety of donepezil in combination with memantine are incomplete and variable ...
Yihan Yang, Sheng Wei, Huan Tian, Jing Cheng, Yue Zhong, Xiaoling Zhong, Dun-bing Huang, Cai Jiang, Xiaohua Ke   +8 more
semanticscholar   +1 more source

Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic

Drug, Healthcare and Patient Safety, 2019
Michael A Veronin,1 Robert P Schumaker,2 Rohit R Dixit,2 Harshini Elath21Social and Administrative Sciences, Department of Pharmaceutical Sciences, University of Texas at Tyler, Ben and Maytee Fisch College of Pharmacy, Tyler, TX 75799, USA; 2Department ...
Veronin MA, Schumaker RP, Dixit RR, Elath H   +3 more
doaj  

Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology
ObjectiveTo comprehensively analyze the ADRs associated with Denosumab (Prolia) in the treatment of osteoporosis using data from the FAERS database, and gain a better understanding of the potential risks and side effects of Denosumab (Prolia) therapy ...
Ruibo Li, Xingyue Yuan, Xi Chen, Yili Ou, Jin Chen   +4 more
doaj   +1 more source

Потенциальный риск повреждения печени на фоне высоких доз ацетоминофена [PDF]

, 2014
ацетоминофенЛЕКАРСТВЕННЫЕ СРЕДСТВА МОДИФИЦИРОВАННЫЕАНЕСТЕЗИРУЮЩИЕ СРЕДСТВА ОБЩЕГО ДЕЙСТВИЯПРОТИВОВОСПАЛИТЕЛЬНЫЕ СРЕДСТВА ...

core  

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases [PDF]

Zhaorui Wang, Linlin Guo, Youfu He, Baiquan Zhang, Yang Wang, Juan Ding   +5 more
openalex   +1 more source